Modulating immunometabolism of tumor specific mouse and human lymphocytes to enhance T cell based therapy for cancer
Year: 2015
Type: article
Abstract: Meeting abstracts Tumor cells and tumor infiltrating lymphocytes (TIL) competes for glucose and other metabolites within the tumor microenvironment for their survival. Glucose consumption by tumors metabolically restricts T cell's ability to produce effector cytokines and therefore approaches to
Institutions: National Institutes of Health, Center for Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2182002985
